Publications by authors named "Imen Fellah-Hebia"

The cause of structural valve deterioration (SVD) is unclear. Therefore, we investigated oxidative stress markers in sera from patients with bioprosthetic heart valves (BHVs) and their association with SVD. Blood samples were taken from SVD (Phase A) and BHV patients during the first 24 (Phase B1) and >48 months (Phase B2) after BHV implantation to assess total antioxidant capacity (TAC), malondialdehyde (MDA), and nitrotyrosine (NT).

View Article and Find Full Text PDF

Bioprosthetic heart valves (BHVs) are commonly used to replace severely diseased heart valves but their susceptibility to structural valve degeneration (SVD) limits their use in young patients. We hypothesized that antibodies against immunogenic glycans present on BHVs, particularly antibodies against the xenoantigens galactose-α1,3-galactose (αGal) and N-glycolylneuraminic acid (Neu5Gc), could mediate their deterioration through calcification. We established a large longitudinal prospective international cohort of patients (n = 1668, 34 ± 43 months of follow-up (0.

View Article and Find Full Text PDF

Background: High consumption of red and processed meat is commonly associated with increased cancer risk, particularly colorectal cancer. Antibodies against the red meat-derived carbohydrate N-glycolylneuraminic acid (Neu5Gc) exacerbate cancer in "human-like" mice. Human anti-Neu5Gc IgG and red meat are both independently proposed to increase cancer risk, yet how diet affects these antibodies is largely unknown.

View Article and Find Full Text PDF
Article Synopsis
  • Research highlights that humans cannot synthesize the sialic acid Neu5Gc, which is found in animal-derived cardiac tissues and bioprosthetic heart valves (BHV), making it a potential target for immune response.
  • Studies showed Neu5Gc expression in porcine and bovine cardiac tissues and BHV, with higher levels of Neu5Gc in pericardium compared to valve tissues.
  • Human antibodies specifically recognize Neu5Gc in BHV, suggesting that this immune response may contribute to the deterioration of bioprosthetic heart valves over time.
View Article and Find Full Text PDF